{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.4:c.100G>A",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "A",
            "position": "100"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "34"
          },
          "Description in input context": "c.100G>A (p.G34S)"
        },
        {
          "HGVS": "NM_000345.4:c.100G>C",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "C",
            "position": "100"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "R",
            "position": "34"
          },
          "Description in input context": "c.100G>C (p.G34R)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinsonism",
    "MONDO": "MONDO:0005252"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "The experiments were conducted using HEK293 cells transiently transfected with wild-type and mutant SNCA constructs."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.100G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased α-synuclein aggregation and phosphorylation in cells expressing c.100G>A (p.G34S) compared to wild-type."
        },
        {
          "Variant": "NM_000345.4:c.100G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Enhanced membrane binding and reduced solubility in cells expressing c.100G>C (p.G34R) compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent biological replicates were performed for each condition."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type SNCA construct was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Unpaired Student's t-test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "α-synuclein phosphorylation levels < 20% of wild-type control.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "α-synuclein phosphorylation levels ≥ 50% of wild-type control.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunohistochemistry",
      "Material used": {
        "Material Source": "Animal Model",
        "Material Name": "Transgenic mice",
        "Description": "Immunohistochemistry was performed on brain tissue from transgenic mice expressing SNCA variants."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.100G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Neuronal loss and Lewy body-like inclusions observed in mice expressing c.100G>A (p.G34S)."
        },
        {
          "Variant": "NM_000345.4:c.100G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Dopaminergic neuron degeneration and increased glial activation in mice expressing c.100G>C (p.G34R)."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Five mice per group were analyzed."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type mice were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-transgenic littermates were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "1"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA followed by post-hoc Tukey's test was used."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "No Lewy body-like inclusions and normal neuronal density.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Presence of Lewy body-like inclusions and ≥ 30% neuronal loss.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}